The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- SPY001, An Anti-α4β7, Shows Promise in Phase 2 SKYLINE Trial for Ulcerative Colitis (HCP Live)
- Recognizing and Treating Iron Deficiency Anemia in Gastrointestinal Disorders (GI & Endoscopy News)
- GLP-1s carry ‘far higher’ than expected risk for residual gastric content during endoscopy (Healio)
- Why GI is at the center of innovation — and what’s holding back the specialty (Becker’s GI & Endoscopy)
- AI remains lacking in clinical reasoning abilities, according to study of 21 large language models (Medical Xpress)
- The top 10 regulatory burdens for medical practices in 2026 (Physicians Practice)
- ctDNA Blood Tests in Colorectal Cancer Screening: High Specificity, Limited Detection of Precancerous Lesions (Healthcare in Europe)
- The Magnetic Flexible Endoscope: Phase 1 First-in-Human Clinical Trial (The American Journal of Gastroenterology)
